Jesse Cook

Jesse Cook


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Journal of Affective Disorders
Verified
Journal Article
Closed access
JCJesse Cook
Jesse Cook
MPMichael L. Prairie
Michael L. Prairie
DPDavid T. Plante
David T. Plante

8 November 2018 in Journal of Sleep Research
Verified
Journal Article
Closed access
PDF file
JCJesse Cook
Jesse Cook
SESahand C. Eftekari
Sahand C. Eftekari
EDErika Dallmann
Erika Dallmann
MSMegan Sippy
Megan Sippy
DPDavid T. Plante
David T. Plante

15 May 2018 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
JCJesse Cook
Jesse Cook
MPMichael L. Prairie
Michael L. Prairie
DPDavid T. Plante
David T. Plante
To evaluate the ability of a multisensory fitness tracker, the Jawbone UP3 (JB3), to quantify and classify sleep in patients with suspected central disorders of hypersomnolence. This study included 43 patients who completed polysomnography (PSG) and a Multiple Sleep Latency Test (MSLT) with concurrent wrist-worn JB3 and Actiwatch 2 (AW2) recordings for comparison. Mean differences in nocturnal sleep architecture variables were compared using Bland-Altman analysis. Sensitivity, specificity, and accuracy were derived for both devices relative to PSG. Ability of the JB3 to detect sleep onset rapid eye movement periods (SOREMPs) during MSLT naps was also quantified. JB3 demonstrated a significant overestimation of total sleep time (39.6 min, P < .0001) relative to PSG, but performed comparably to AW2. Although the ability of the JB3 to detect epochs of sleep was relatively good (sensitivity = 0.97), its ability to distinguish light, deep, and REM sleep was poor. Similarly, the JB3 did not correctly identify a single SOREMP during any MSLT nap opportunity. The JB3 did not accurately quantify or classify sleep in patients with suspected central disorders of hypersomnolence, and was particularly poor at identifying REM sleep. Thus, this device cannot be used as a surrogate for PSG or MSLT in the assessment of patients with suspected central disorders of hypersomnolence.

1 February 2017 in Journal of Sleep Research
Verified
Journal Article
Open access
PDF file
DPDavid T. Plante
David T. Plante
JCJesse Cook
Jesse Cook
MGMichael R Goldstein
Michael R Goldstein
Summary: Hypersomnolence plays an important role in the presentation, treatment and course of mood disorders. However, there has been relatively little research that examines objective measures of sleep duration and continuity in patients with depression and hypersomnolence, despite the use of these factors in sleep medicine nosological systems. This study compared total sleep time and efficiency measured by naturalistic actigraphic recordings followed by ad libitum polysomnography (PSG; without prescribed wake time) in 22 patients with major depressive disorder and co‐occurring hypersomnolence against age‐ and sex‐matched healthy sleeper controls. The major depressive disorder and co‐occurring hypersomnolence group demonstrated significantly longer sleep duration compared with healthy sleeper controls quantified by sleep diaries, actigraphy and ad libitum PSG. No between‐group differences in sleep efficiency (SE), latency to sleep or wake after sleep onset were observed when assessed using objective measures. To further contextualize these findings within the broader scientific literature, a systematic review was performed to identify other comparable investigations. A meta‐analysis of pooled data demonstrated patients with mood disorders and co‐occurring hypersomnolence have significantly greater sleep duration and similar SE compared with healthy controls when assessed using ad libitum PSG. These results suggest current sleep medicine nosology that distinguishes hypersomnia associated with psychiatric disorders primarily as a construct characterized by low SE and increased time in bed may not be accurate. Future studies that establish the biological bases hypersomnolence in mood disorders, as well as clarify the accuracy of nosological thresholds to define excessive sleep duration, are needed to refine the diagnosis and treatment of these disorders.

15 April 2019 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Open access
JCJesse Cook
Jesse Cook
SESahand C. Eftekari
Sahand C. Eftekari
LLLydia A. Leavitt
Lydia A. Leavitt
MPMichael L. Prairie
Michael L. Prairie
DPDavid T. Plante
David T. Plante
Study Objectives:To determine the optimal Actiwatch 2 setting configuration for the estimation of total sleep time (TST) in persons with suspected idiopathic hypersomnia.Methods:Thirty-three patien...

18 August 2022 in Chronobiology International
Verified
Journal Article
Closed access
JCJesse Cook
Jesse Cook
JCJonathan Charest
Jonathan Charest
OWOlivia Walch
Olivia Walch
ABAmy M. Bender
Amy M. Bender
This investigation aimed to clarify the influence of circadian change and travel distance on National Basketball Association (NBA) team performance using a dataset from the 2014–2018 seasons. Data from 9,840 games were acquired from an open-access source. Game point differential and team free-throw percentage served as outcome variables. Time zone change (TZΔ) captured raw circadian delay/advance based on travel for a game and adjusted TZΔ (AdjTZΔ) evolved TZΔ by allowing acclimation to a novel TZ. We also further categorized AdjTZΔ into AdjTZΔ_A, which assumed travel the day before each game and AdjTZΔ_B, which assumed teams spent as many days in their home city as possible. Travel distance for each game was calculated. Linear mixed-effects modeling estimated associations, with games nested within team and year. Adjusted associations accounted for differences in team ability, whether the game was home or away, and whether the game occurred on the second half of a back-to-back game sequence. Greater circadian misalignment, regardless of delay or advance, and increasing travel distance negatively influenced NBA game performance. Yet, results suggest that performance outcomes may be more influenced by travel distance than circadian misalignment. Moreover, circadian misalignment and travel distance interacted to significantly influence game point differential. Furthermore, differences in results across analyses were observed between AdjTZΔ_A and AdjTZΔ_B, which suggests that subtle differences in constructed travel schedules can have notable impact on NBA performance outcomes. Lastly, playing on the second half of a back-to-back sequence emerged as a robust predictor of performance disadvantage, which corroborates the existing literature and provides further support for NBA schedule changes purposed to enhance competitive equity by reducing the number of back-to-back games across a season. These findings can help guide NBA teams on key strategies for reducing travel-related disadvantages and inform schedule makers on critical factors to prioritize across future schedules to attenuate competitive inequity from travel. Furthermore, they can help direct teams towards scenarios that are best to target for load management purposes due to the cumulative disadvantage arising from travel-related factors, opponent quality, game location, and game sequence.